Jump to content

A randomised phase II study of carmustine alone or in combination with tumour necrosis factor in patients with advanced melanoma (Q68126733)

From Wikidata

scientific article published on 01 January 1992

Language	Label	Description	Also known as
default for all languages	No label defined
English	A randomised phase II study of carmustine alone or in combination with tumour necrosis factor in patients with advanced melanoma	scientific article published on 01 January 1992

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1586984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

A randomised phase II study of carmustine alone or in combination with tumour necrosis factor in patients with advanced melanoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1586984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

author name string

A. L. Jones

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1586984

11 October 2022

M. E. O'Brien

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1586984

11 October 2022

A. Lorentzos

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1586984

11 October 2022

C. Viner

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1586984

11 October 2022

A. Hanrahan

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1586984

11 October 2022

J. Moore

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1586984

11 October 2022

J. L. Millar

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1586984

11 October 2022

M. E. Gore

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1586984

11 October 2022

publication date

1 January 1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1586984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1586984

11 October 2022

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1586984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1586984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1586984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

73-76

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1586984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Cachectin: more than a tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/1586984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DTIC (NSC-45388) in malignant melanoma: a perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/1586984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human tumor necrosis factor alone and with chemotherapeutic agents. Effect on nude mouse-supported human bladder cancer heterografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/1586984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour necrosis factor: clinical relevance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1586984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of tumour necrosis factor on cultured human melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1586984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nitrosoureas in the management of disseminated malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1586984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic chemotherapy for metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1586984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit

1 reference

https://pubmed.ncbi.nlm.nih.gov/1586984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1586984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced anti-tumour activity of carmustine (BCNU) with tumour necrosis factor in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/1586984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour necrosis factor in man: clinical and biological observations

1 reference

https://pubmed.ncbi.nlm.nih.gov/1586984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/1586984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/1586984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic enhancement by tumor necrosis factor of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1586984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant tumor necrosis factor: species specificity for a variety of human and murine transformed cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/1586984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00686489

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1586984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1586984%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68126733&oldid=2218473504"